Bedikian AY, Johnson MM, et al. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.J Immunotoxicol. 2008 Apr;5(2):201-7.
Eggermont AM, Robert C. New drugs in melanoma: It's a whole new world.Eur J Cancer. 2011 Sep;47(14):2150-2157.
Hancock BW, Wheatley K, et al. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.J Clin Oncol. 2004;22(1):11-4;7-10.
Lens M. The role of vaccine therapy in the treatment of melanoma.Expert Opin Biol Ther. 2008 Mar;8(3):315-23. Review.
Lipson EJ, Drake CG. Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.Clin Cancer Res. 2011 Sep 7.
Melanoma. EBSCO DynaMed website. Available at:https://dynamed.ebscohost.com/about/about-us. Updated April 3, 2013. Accessed April 10, 2013.
Melanoma skin cancer. American Cancer Society website. Available at:http://www.cancer.org/acs/groups/cid/documents/webcontent/003120-pdf.pdf. Updated January 17, 2013. Accessed April 10, 2013.
Melanoma treatment. Treatment options by stage. National Cancer Institute website. Available at:http://www.cancer.gov/cancertopics/pdq/treatment/melanoma/Patient/page5. Updated March 29, 2013. Accessed April 10, 2013.
Stein JA, Brownell I. Treatment approaches for advanced cutaneous melanoma.J Drugs Dermatol. 2008 Feb;7(2):175-9.